Share Price and Basic Stock Data
Last Updated: February 13, 2026, 10:21 pm
| PEG Ratio | 0.12 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Forbes & Company Ltd operates in the engineering sector, reporting a market capitalization of ₹496 Cr. The company’s recent revenue trends indicate significant volatility, particularly in the last fiscal year. For instance, total sales for FY 2025 stood at ₹199 Cr, a stark decline from ₹515 Cr in FY 2022, reflecting the challenges encountered during the pandemic and subsequent recovery phases. Quarterly sales showed fluctuations, with the highest reported in March 2025 at ₹88.68 Cr, contrasting sharply with lower figures of ₹11.26 Cr in March 2023. This indicates a potential recovery trajectory, although the trailing twelve months (TTM) revenue of ₹170 Cr suggests ongoing instability. The sales figures are indicative of a company navigating through challenging market conditions, and the significant drop in sales from FY 2022 to FY 2023 highlights the need for strategic initiatives to stabilize revenue generation.
Profitability and Efficiency Metrics
Forbes & Company Ltd’s profitability metrics illustrate a challenging landscape, with a reported net profit of ₹124 Cr and a P/E ratio of 21.6. The operating profit margins (OPM) have fluctuated significantly, recorded at 16.97% in the latest quarter, but also reflecting negative margins in earlier quarters of FY 2023, such as -32.68% in March 2023. The return on equity (ROE) is notably high at 62.4%, indicating effective utilization of equity capital, while the return on capital employed (ROCE) stands at a modest 15.8%. The cash conversion cycle (CCC) is remarkably efficient at -13 days, which suggests that the company is effective in managing its receivables and payables. However, the historical volatility in profitability, especially the negative operating profits during the previous fiscal year, raises concerns about sustainability in profit generation.
Balance Sheet Strength and Financial Ratios
The balance sheet of Forbes & Company Ltd reflects a conservative financial structure, with total borrowings recorded at ₹6 Cr against reserves of ₹217 Cr. This low level of debt indicates a strong equity position, providing financial flexibility for future investments or operational adjustments. The interest coverage ratio (ICR) is exceptionally high at 83.50x, suggesting that the company can easily meet its interest obligations, which is a positive indicator of financial health. The price-to-book value (P/BV) ratio stands at 1.71x, which is lower than typical sector averages, indicating that the stock may be undervalued relative to its book value. The current ratio of 1.61x further demonstrates a healthy liquidity position, enabling the company to cover short-term liabilities comfortably. However, the historical fluctuations in total liabilities and asset turnover ratios raise questions about long-term operational efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Forbes & Company Ltd reveals a strong promoter holding at 73.85%, indicating significant control and confidence from the founding members. Foreign institutional investors (FIIs) hold a minority stake of 8.24%, while domestic institutional investors (DIIs) account for a mere 0.19%, suggesting limited institutional interest. The public shareholding has increased to 16.85%, reflecting a slight uptick in retail investor confidence. The decline in the number of shareholders from 13,830 in March 2023 to 12,391 in December 2025 indicates potential concerns among investors regarding the company’s performance. The high promoter stake is a double-edged sword; while it shows commitment, it also raises the question of whether there is sufficient liquidity in the stock for broader market participation.
Outlook, Risks, and Final Insight
Looking ahead, Forbes & Company Ltd faces both opportunities and risks. On one hand, the potential for revenue recovery is bolstered by the recent uptick in quarterly sales, suggesting a possible rebound in demand. However, the ongoing volatility in profit margins and the company’s ability to sustain operational efficiency remain critical risks. Moreover, the reliance on a small group of promoters could limit the company’s responsiveness to market changes. If the company successfully navigates these challenges and leverages its strong balance sheet, it could position itself for growth. Conversely, failure to stabilize revenue and maintain profitability could hinder investor confidence and adversely affect stock performance. The next few quarters will be pivotal in determining whether Forbes & Company can capitalize on its strengths while mitigating inherent risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 211 Cr. | 622 | 1,028/511 | 16.7 | 218 | 0.48 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 24.0 Cr. | 80.0 | 112/58.9 | 19.9 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 5.73 Cr. | 13.2 | 16.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 7.39 Cr. | 12.0 | 16.0/10.2 | 4.25 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 39.2 Cr. | 0.42 | 4.69/0.40 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 | |
| Industry Average | 3,636.86 Cr | 461.00 | 40.71 | 118.57 | 0.31% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60.75 | 11.26 | 11.37 | 15.54 | 11.89 | 87.08 | 35.79 | 34.66 | 40.23 | 88.68 | 22.45 | 18.70 | 17.80 |
| Expenses | 63.60 | 14.94 | 11.30 | 17.04 | 11.81 | 83.58 | 31.00 | 30.45 | 36.75 | 77.13 | 21.30 | 15.83 | 14.78 |
| Operating Profit | -2.85 | -3.68 | 0.07 | -1.50 | 0.08 | 3.50 | 4.79 | 4.21 | 3.48 | 11.55 | 1.15 | 2.87 | 3.02 |
| OPM % | -4.69% | -32.68% | 0.62% | -9.65% | 0.67% | 4.02% | 13.38% | 12.15% | 8.65% | 13.02% | 5.12% | 15.35% | 16.97% |
| Other Income | 8.15 | 14.10 | 17.40 | -20.24 | 2.96 | -1.03 | 2.31 | 2.60 | 10.19 | 97.29 | 5.34 | 6.22 | 2.55 |
| Interest | 3.51 | -0.90 | 0.24 | 0.39 | 0.17 | 0.80 | 0.23 | 0.20 | 0.21 | 0.13 | 0.16 | 0.15 | 0.16 |
| Depreciation | 4.49 | 1.36 | 0.41 | 0.46 | 0.35 | 0.43 | 0.38 | 0.37 | 0.42 | 0.41 | 0.57 | 0.56 | 0.52 |
| Profit before tax | -2.70 | 9.96 | 16.82 | -22.59 | 2.52 | 1.24 | 6.49 | 6.24 | 13.04 | 108.30 | 5.76 | 8.38 | 4.89 |
| Tax % | 51.11% | -2.71% | 36.09% | 0.53% | -55.95% | -173.39% | 18.64% | 17.63% | 27.15% | 5.04% | 15.62% | 24.46% | 14.31% |
| Net Profit | -4.08 | 10.23 | 10.75 | -22.71 | 3.93 | 3.39 | 5.28 | 5.14 | 9.50 | 102.84 | 4.86 | 6.33 | 4.19 |
| EPS in Rs | -3.16 | 7.93 | 8.33 | -17.60 | 3.05 | 2.63 | 4.09 | 3.98 | 7.36 | 79.72 | 3.77 | 4.91 | 3.25 |
Last Updated: February 1, 2026, 11:46 pm
Below is a detailed analysis of the quarterly data for Forbes & Company Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 17.80 Cr.. The value appears to be declining and may need further review. It has decreased from 18.70 Cr. (Sep 2025) to 17.80 Cr., marking a decrease of 0.90 Cr..
- For Expenses, as of Dec 2025, the value is 14.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.83 Cr. (Sep 2025) to 14.78 Cr., marking a decrease of 1.05 Cr..
- For Operating Profit, as of Dec 2025, the value is 3.02 Cr.. The value appears strong and on an upward trend. It has increased from 2.87 Cr. (Sep 2025) to 3.02 Cr., marking an increase of 0.15 Cr..
- For OPM %, as of Dec 2025, the value is 16.97%. The value appears strong and on an upward trend. It has increased from 15.35% (Sep 2025) to 16.97%, marking an increase of 1.62%.
- For Other Income, as of Dec 2025, the value is 2.55 Cr.. The value appears to be declining and may need further review. It has decreased from 6.22 Cr. (Sep 2025) to 2.55 Cr., marking a decrease of 3.67 Cr..
- For Interest, as of Dec 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.15 Cr. (Sep 2025) to 0.16 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Dec 2025, the value is 0.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.56 Cr. (Sep 2025) to 0.52 Cr., marking a decrease of 0.04 Cr..
- For Profit before tax, as of Dec 2025, the value is 4.89 Cr.. The value appears to be declining and may need further review. It has decreased from 8.38 Cr. (Sep 2025) to 4.89 Cr., marking a decrease of 3.49 Cr..
- For Tax %, as of Dec 2025, the value is 14.31%. The value appears to be improving (decreasing) as expected. It has decreased from 24.46% (Sep 2025) to 14.31%, marking a decrease of 10.15%.
- For Net Profit, as of Dec 2025, the value is 4.19 Cr.. The value appears to be declining and may need further review. It has decreased from 6.33 Cr. (Sep 2025) to 4.19 Cr., marking a decrease of 2.14 Cr..
- For EPS in Rs, as of Dec 2025, the value is 3.25. The value appears to be declining and may need further review. It has decreased from 4.91 (Sep 2025) to 3.25, marking a decrease of 1.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,067 | 3,546 | 3,231 | 2,999 | 2,822 | 2,853 | 2,731 | 932 | 515 | 47 | 125 | 199 | 170 |
| Expenses | 2,914 | 3,417 | 3,194 | 2,892 | 2,693 | 2,710 | 2,701 | 821 | 465 | 76 | 119 | 173 | 151 |
| Operating Profit | 153 | 129 | 37 | 106 | 129 | 143 | 30 | 111 | 49 | -29 | 6 | 26 | 19 |
| OPM % | 5% | 4% | 1% | 4% | 5% | 5% | 1% | 12% | 10% | -63% | 5% | 13% | 11% |
| Other Income | 52 | 65 | 135 | 134 | 39 | 35 | -171 | -48 | 4,252 | 243 | -5 | 110 | 119 |
| Interest | 79 | 91 | 107 | 74 | 96 | 89 | 101 | 52 | 42 | 10 | 1 | 1 | 1 |
| Depreciation | 54 | 22 | 75 | 71 | 77 | 77 | 98 | 68 | 41 | 6 | 2 | 2 | 2 |
| Profit before tax | 72 | 81 | -9 | 95 | -4 | 11 | -341 | -56 | 4,218 | 198 | -2 | 134 | 135 |
| Tax % | 30% | 54% | 423% | 26% | 682% | 126% | -1% | 107% | -0% | 3% | 116% | 8% | |
| Net Profit | 50 | 37 | -48 | 89 | -32 | -3 | -338 | -117 | 4,229 | 192 | -4 | 123 | 124 |
| EPS in Rs | 31.05 | 25.17 | -45.39 | 65.49 | -15.07 | 5.40 | -251.63 | -60.21 | 3,278.84 | 148.80 | -3.46 | 95.16 | 95.76 |
| Dividend Payout % | 0% | 0% | 0% | 4% | -17% | 93% | 0% | 0% | 0% | 44% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.00% | -229.73% | 285.42% | -135.96% | 90.62% | -11166.67% | 65.38% | 3714.53% | -95.46% | -102.08% | 3175.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -203.73% | 515.15% | -421.37% | 226.58% | -11257.29% | 11232.05% | 3649.15% | -3809.99% | -6.62% | 3277.08% |
Forbes & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -25% |
| 5 Years: | -41% |
| 3 Years: | -27% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 23% |
| 3 Years: | -71% |
| TTM: | 76% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 68% |
| 3 Years: | 12% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| Last Year: | 62% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 398 | 431 | 206 | 301 | 303 | 251 | -101 | -154 | 73 | 212 | 127 | 207 | 217 |
| Borrowings | 918 | 1,180 | 1,140 | 1,164 | 1,189 | 1,070 | 1,137 | 523 | 288 | 9 | 5 | 5 | 6 |
| Other Liabilities | 1,160 | 1,188 | 1,220 | 1,228 | 1,254 | 1,541 | 1,695 | 1,654 | 415 | 467 | 275 | 77 | 65 |
| Total Liabilities | 2,488 | 2,811 | 2,579 | 2,706 | 2,759 | 2,874 | 2,744 | 2,036 | 789 | 701 | 421 | 301 | 302 |
| Fixed Assets | 878 | 1,140 | 997 | 1,036 | 1,139 | 1,134 | 1,027 | 598 | 158 | 29 | 27 | 27 | 27 |
| CWIP | 29 | 51 | 72 | 74 | 94 | 87 | 29 | 4 | 1 | 0 | 0 | 0 | 0 |
| Investments | 10 | 26 | 92 | 73 | 80 | 81 | 123 | 60 | 117 | 145 | 171 | 200 | 208 |
| Other Assets | 1,571 | 1,594 | 1,418 | 1,524 | 1,445 | 1,573 | 1,565 | 1,374 | 513 | 527 | 223 | 74 | 66 |
| Total Assets | 2,488 | 2,811 | 2,579 | 2,706 | 2,759 | 2,874 | 2,744 | 2,036 | 789 | 701 | 421 | 301 | 302 |
Below is a detailed analysis of the balance sheet data for Forbes & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 217.00 Cr.. The value appears strong and on an upward trend. It has increased from 207.00 Cr. (Mar 2025) to 217.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 65.00 Cr.. The value appears to be improving (decreasing). It has decreased from 77.00 Cr. (Mar 2025) to 65.00 Cr., marking a decrease of 12.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 302.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 301.00 Cr. (Mar 2025) to 302.00 Cr., marking an increase of 1.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 208.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2025) to 208.00 Cr., marking an increase of 8.00 Cr..
- For Other Assets, as of Sep 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 66.00 Cr., marking a decrease of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 302.00 Cr.. The value appears strong and on an upward trend. It has increased from 301.00 Cr. (Mar 2025) to 302.00 Cr., marking an increase of 1.00 Cr..
Notably, the Reserves (217.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -765.00 | 128.00 | 36.00 | 105.00 | 128.00 | 142.00 | 29.00 | -412.00 | -239.00 | -38.00 | 1.00 | 21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 60 | 59 | 56 | 54 | 60 | 54 | 47 | 62 | 61 | 20 | 15 |
| Inventory Days | 131 | 102 | 98 | 138 | 155 | 220 | 284 | 188 | 533 | 892 | 43 | |
| Days Payable | 192 | 162 | 140 | 115 | 142 | 151 | 162 | 99 | 214 | 217 | 71 | |
| Cash Conversion Cycle | 5 | 0 | 17 | 79 | 68 | 128 | 177 | 136 | 380 | 61 | 695 | -13 |
| Working Capital Days | -32 | -17 | -29 | -27 | -42 | -71 | -126 | -273 | -135 | -175 | -299 | -49 |
| ROCE % | 14% | 11% | 3% | 5% | 5% | 7% | -2% | 14% | 12% | -9% | 5% | 16% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 96.42 | -3.50 | 150.77 | 3319.02 | -61.00 |
| Diluted EPS (Rs.) | 96.42 | -3.50 | 150.77 | 3319.02 | -64.00 |
| Cash EPS (Rs.) | 97.73 | -0.53 | 167.51 | 3298.18 | -21.47 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 170.16 | 60.88 | 126.35 | 63.87 | -66.31 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 170.16 | 60.88 | 126.35 | 63.87 | -66.31 |
| Revenue From Operations / Share (Rs.) | 154.46 | 97.60 | 342.65 | 399.06 | 2214.80 |
| PBDIT / Share (Rs.) | 34.16 | 23.06 | 193.00 | 65.03 | 208.82 |
| PBIT / Share (Rs.) | 32.94 | 21.79 | 171.91 | 32.91 | 133.43 |
| PBT / Share (Rs.) | 32.51 | 18.22 | 167.59 | -271.19 | -28.06 |
| Net Profit / Share (Rs.) | 96.51 | -1.81 | 146.42 | 3266.05 | -96.86 |
| NP After MI And SOA / Share (Rs.) | 95.17 | -3.46 | 148.82 | 3276.21 | -60.21 |
| PBDIT Margin (%) | 22.11 | 23.62 | 56.32 | 16.29 | 9.42 |
| PBIT Margin (%) | 21.32 | 22.32 | 50.16 | 8.24 | 6.02 |
| PBT Margin (%) | 21.04 | 18.66 | 48.90 | -67.95 | -1.26 |
| Net Profit Margin (%) | 62.48 | -1.85 | 42.73 | 818.44 | -4.37 |
| NP After MI And SOA Margin (%) | 61.61 | -3.54 | 43.43 | 820.99 | -2.71 |
| Return on Networth / Equity (%) | 55.93 | -5.67 | 117.78 | 5116.97 | 0.00 |
| Return on Capital Employeed (%) | 17.19 | 17.86 | 76.07 | 23.27 | 52.91 |
| Return On Assets (%) | 40.27 | -1.05 | 27.37 | 530.11 | -3.80 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.11 | 0.81 | -1.63 |
| Total Debt / Equity (X) | 0.00 | 0.05 | 0.31 | 3.33 | -4.19 |
| Asset Turnover Ratio (%) | 0.54 | 0.22 | 0.37 | 0.18 | 0.34 |
| Current Ratio (X) | 1.61 | 0.86 | 0.92 | 0.72 | 0.61 |
| Quick Ratio (X) | 1.36 | 0.40 | 0.40 | 0.39 | 0.34 |
| Inventory Turnover Ratio (X) | 2.93 | 0.11 | 0.48 | 0.25 | 0.13 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 43.11 | 96.21 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 37.76 | 95.28 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 56.89 | 3.79 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 62.24 | 4.72 | 0.00 |
| Interest Coverage Ratio (X) | 83.50 | 18.55 | 14.15 | 2.00 | 3.10 |
| Interest Coverage Ratio (Post Tax) (X) | 59.08 | 15.99 | 11.02 | 1.25 | 1.06 |
| Enterprise Value (Cr.) | 348.67 | 527.07 | 739.90 | 782.54 | 2819.46 |
| EV / Net Operating Revenue (X) | 1.75 | 4.19 | 1.67 | 1.52 | 0.98 |
| EV / EBITDA (X) | 7.91 | 17.72 | 2.97 | 9.33 | 10.47 |
| MarketCap / Net Operating Revenue (X) | 1.89 | 4.43 | 1.71 | 1.03 | 0.77 |
| Retention Ratios (%) | 0.00 | 0.00 | 56.88 | 3.78 | 0.00 |
| Price / BV (X) | 1.71 | 7.10 | 4.63 | 6.41 | -14.83 |
| Price / Net Operating Revenue (X) | 1.89 | 4.43 | 1.71 | 1.03 | 0.77 |
| EarningsYield | 0.32 | -0.01 | 0.25 | 7.98 | -0.03 |
After reviewing the key financial ratios for Forbes & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 96.42. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 96.42, marking an increase of 99.92.
- For Diluted EPS (Rs.), as of Mar 25, the value is 96.42. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 96.42, marking an increase of 99.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 97.73. This value is within the healthy range. It has increased from -0.53 (Mar 24) to 97.73, marking an increase of 98.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 170.16. It has increased from 60.88 (Mar 24) to 170.16, marking an increase of 109.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 170.16. It has increased from 60.88 (Mar 24) to 170.16, marking an increase of 109.28.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 154.46. It has increased from 97.60 (Mar 24) to 154.46, marking an increase of 56.86.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 34.16. This value is within the healthy range. It has increased from 23.06 (Mar 24) to 34.16, marking an increase of 11.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 32.94. This value is within the healthy range. It has increased from 21.79 (Mar 24) to 32.94, marking an increase of 11.15.
- For PBT / Share (Rs.), as of Mar 25, the value is 32.51. This value is within the healthy range. It has increased from 18.22 (Mar 24) to 32.51, marking an increase of 14.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 96.51. This value is within the healthy range. It has increased from -1.81 (Mar 24) to 96.51, marking an increase of 98.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 95.17. This value is within the healthy range. It has increased from -3.46 (Mar 24) to 95.17, marking an increase of 98.63.
- For PBDIT Margin (%), as of Mar 25, the value is 22.11. This value is within the healthy range. It has decreased from 23.62 (Mar 24) to 22.11, marking a decrease of 1.51.
- For PBIT Margin (%), as of Mar 25, the value is 21.32. This value exceeds the healthy maximum of 20. It has decreased from 22.32 (Mar 24) to 21.32, marking a decrease of 1.00.
- For PBT Margin (%), as of Mar 25, the value is 21.04. This value is within the healthy range. It has increased from 18.66 (Mar 24) to 21.04, marking an increase of 2.38.
- For Net Profit Margin (%), as of Mar 25, the value is 62.48. This value exceeds the healthy maximum of 10. It has increased from -1.85 (Mar 24) to 62.48, marking an increase of 64.33.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 61.61. This value exceeds the healthy maximum of 20. It has increased from -3.54 (Mar 24) to 61.61, marking an increase of 65.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 55.93. This value is within the healthy range. It has increased from -5.67 (Mar 24) to 55.93, marking an increase of 61.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 17.19, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 40.27. This value is within the healthy range. It has increased from -1.05 (Mar 24) to 40.27, marking an increase of 41.32.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.54. It has increased from 0.22 (Mar 24) to 0.54, marking an increase of 0.32.
- For Current Ratio (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has increased from 0.86 (Mar 24) to 1.61, marking an increase of 0.75.
- For Quick Ratio (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.40 (Mar 24) to 1.36, marking an increase of 0.96.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 4. It has increased from 0.11 (Mar 24) to 2.93, marking an increase of 2.82.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 83.50. This value is within the healthy range. It has increased from 18.55 (Mar 24) to 83.50, marking an increase of 64.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 59.08. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 59.08, marking an increase of 43.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 348.67. It has decreased from 527.07 (Mar 24) to 348.67, marking a decrease of 178.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has decreased from 4.19 (Mar 24) to 1.75, marking a decrease of 2.44.
- For EV / EBITDA (X), as of Mar 25, the value is 7.91. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 7.91, marking a decrease of 9.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 4.43 (Mar 24) to 1.89, marking a decrease of 2.54.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 7.10 (Mar 24) to 1.71, marking a decrease of 5.39.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 4.43 (Mar 24) to 1.89, marking a decrease of 2.54.
- For EarningsYield, as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.32, marking an increase of 0.33.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Forbes & Company Ltd:
- Net Profit Margin: 62.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.19% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 55.93% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 59.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.2 (Industry average Stock P/E: 40.71)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 62.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | Forbes Building, Mumbai Maharashtra 400001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M C Tahilyani | Chairman & Non-Exe.Director |
| Mr. Nirmal Jagawat | Whole Time Director |
| Mr. Jai L Mavani | Non Executive Director |
| Mr. Nikhil Bhatia | Independent Director |
| Mr. Paras Savla | Independent Director |
| Mr. Bapsy Dastur | Independent Director |
FAQ
What is the intrinsic value of Forbes & Company Ltd?
Forbes & Company Ltd's intrinsic value (as of 14 February 2026) is ₹5032.79 which is 1294.12% higher the current market price of ₹361.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹466 Cr. market cap, FY2025-2026 high/low of ₹477/264, reserves of ₹217 Cr, and liabilities of ₹302 Cr.
What is the Market Cap of Forbes & Company Ltd?
The Market Cap of Forbes & Company Ltd is 466 Cr..
What is the current Stock Price of Forbes & Company Ltd as on 14 February 2026?
The current stock price of Forbes & Company Ltd as on 14 February 2026 is ₹361.
What is the High / Low of Forbes & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Forbes & Company Ltd stocks is ₹477/264.
What is the Stock P/E of Forbes & Company Ltd?
The Stock P/E of Forbes & Company Ltd is 20.2.
What is the Book Value of Forbes & Company Ltd?
The Book Value of Forbes & Company Ltd is 178.
What is the Dividend Yield of Forbes & Company Ltd?
The Dividend Yield of Forbes & Company Ltd is 0.00 %.
What is the ROCE of Forbes & Company Ltd?
The ROCE of Forbes & Company Ltd is 15.8 %.
What is the ROE of Forbes & Company Ltd?
The ROE of Forbes & Company Ltd is 62.4 %.
What is the Face Value of Forbes & Company Ltd?
The Face Value of Forbes & Company Ltd is 10.0.